Exploratory study to investigate biomarkers associated with pathogenesis of infantile hemangioma.
Not Applicable
- Conditions
- Infantile hemangioma
- Registration Number
- JPRN-UMIN000038574
- Lead Sponsor
- Wakayama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
1)Internal type 2)Patients who need to start treatment of infantile hemangioma before proliferating phase and the initiation of study. 3)Patients taking medications that may affect infantile hemangioma pathology and levels of biomarker before the study 4)Patients suspected of serious complications and diseases that greatly affect cytokine levels through interview by the doctors (PHACE syndrome, infection and inflammatory diseases, etc).
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Volume of infantile hemangioma in proliferating phase.
- Secondary Outcome Measures
Name Time Method